Chambers Review
Provided by Chambers
Private Equity: Buyouts & Venture Capital Investment (International Firms) - China
What the Team is Known For
Paul Hastings advises on private equity deals for a client roster featuring Chinese and international private equity houses and funds. The team remains highly focused on private equity investments in the real estate sector, with the capacity to advise throughout Asia. It has a strong track record of handling TMT-related transactions.
Strengths
They are very commercial and take a balanced approach, providing creative solutions in addition to standard legal advice.
We're really happy. They were able to link us up with people through their network too.
Paul Hastings is a very sophisticated firm.
Work Highlights
Paul Hastings advised GenScript Biotech and its subsidiary Probio Technology on Probio’s Series C financing, raising approximately USD224 million.
Notable practitioners
David Wang in Shanghai and Beijing is a key contact.